Whole-exome sequencing has moved from a research tool to a clinical option in pediatric neurology over the past decade. This article explains when WES is recommended after HIE, what it can find, what the results mean for prognosis and future pregnancies, and how to think about it as a parent.
Why Genetic Testing Is Discussed After HIE
HIE is typically a clinical diagnosis: a constellation of findings (acidotic cord gas, low Apgar scores, encephalopathy on exam, characteristic MRI changes) following an apparent perinatal event. But not every case fits cleanly. When the prenatal course was unremarkable, the delivery was uncomplicated, or the MRI findings are atypical, clinicians increasingly consider whether a genetic condition may be contributing. Genetic conditions can mimic HIE (causing newborn encephalopathy that looks similar), make a baby more vulnerable to perinatal stress (so a relatively minor event causes major injury), or coexist with HIE (where both are present and both shape outcome). WES helps clarify which of these is at play.
What WES Actually Tests
The exome is the protein-coding portion of the genome (about 1 to 2 percent of total DNA but where most known disease-causing mutations occur). WES reads thousands of genes simultaneously and looks for variants that may explain the clinical picture. It is broader than gene-panel testing (which targets a specific list of genes) and faster than whole-genome sequencing (which is rarely needed). Results typically come back in 4 to 12 weeks. The lab reports findings as pathogenic, likely pathogenic, variant of uncertain significance (VUS), or normal. Interpretation requires clinical correlation, which is why a geneticist is involved.
Even when genetic testing is being pursued, the question of whether delivery management contributed to the injury is separate. A free legal review can help you understand both pictures.
When Doctors Recommend WES After HIE
Common scenarios where WES is recommended include: the prenatal course was unremarkable but the baby was profoundly encephalopathic at birth; the MRI shows patterns not typical for HIE (such as cortical malformation or selective gray matter abnormalities); seizures are unusually severe or refractory; family history includes neurological conditions, miscarriage, or unexplained childhood deaths; physical exam reveals dysmorphic features or other organ involvement; or developmental trajectory is worse than the imaging would predict. Each of these raises the question of an underlying genetic contribution.
What the Results Can Mean
A pathogenic finding can lead to specific changes in care. For example, mitochondrial disorders may benefit from particular medication considerations and avoidance of certain anesthetics. Channelopathies may guide seizure medication choice. Some metabolic conditions have specific dietary management. Even when no targeted treatment exists, knowing the cause helps families understand prognosis, plan future pregnancies (with options for prenatal diagnosis or preimplantation genetic testing), and connect with condition-specific support communities. A negative or VUS result is also informative: it strengthens the case that HIE is the primary explanation.
Cost, Insurance, and Logistics
WES is widely covered by major insurance and Medicaid when ordered for an appropriate clinical indication, especially for an infant with neonatal encephalopathy and an uncertain or atypical picture. Out-of-pocket costs without coverage can range from several hundred to several thousand dollars depending on the lab. Most academic medical centers have established workflows that include pre-authorization, sample collection, and post-test counseling. Trio testing (sequencing the baby and both parents) is preferred and improves the diagnostic yield substantially.
Genetic Counseling: Before and After
Genetic counselors and pediatric geneticists play a central role. Before testing, they discuss what WES can and cannot tell you, what kinds of findings might come back, and what the implications might be for the family. After results, they help interpret what was found, plan any additional testing, discuss recurrence risk for future pregnancies, and connect families to resources. Many parents find this counseling reassuring even when results are unexpected. The honest framing: genetic information is powerful but rarely answers every question. Most diagnoses are still primarily managed through clinical care and therapy.
Talking with the Team About WES
Bring this list to your pediatric neurology or genetics appointment.
Will a genetic finding change my child’s care?
Sometimes. Specific diagnoses can change medication choices (especially anti-seizure drugs and anesthesia considerations), trigger metabolic management, or open clinical trial eligibility. Even when the finding does not lead to a different treatment, it changes prognosis estimates and informs family planning.
What about variants of uncertain significance (VUS)?
VUS results are common and frustrating. They mean the lab found a variant whose clinical significance is not yet known. Most VUS are not the cause of disease, but reclassification can happen as more cases are reported. Genetics teams typically recheck the variant database periodically and update families if a reclassification occurs.
We connect families with pediatric specialists across 38 states for complex HIE diagnostic work-ups.
Related reading for parents
- Genetic causes of cerebral palsy: when CP isn’t caused by birth injury
- Conditions that mimic cerebral palsy: differential diagnosis parents should know
- HIE MRI results explained: what the findings really mean
- Grades of HIE: mild, moderate, and severe explained
- Planning a second pregnancy after HIE: recurrence risk and monitoring
Our team helps families in 38 states understand the full clinical picture and what services should be in place. No cost. Answers first.
